Engaging Thought Leadership
Over 75 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
Discovery US 2024
07 - 08 November 2024 | Boston, MA
Connecting experts in biology & chemistry to advance small molecule drug discovery
Discovery US 2024
Meet Our Expert Speakers
Discovery US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Below are some of our featured speakers:
Abhijat Vatsyayan
Head of Artificial Intelligence,
Taiho Oncology
Divya Kanichar
Director,
Insitro
Fiona Mack
Vice President,
Bayer
Giovanni Piedimonte
Vice President of Research,
Tulane University
Hong Cheng
Vice President, Head of Research Strategy,
Sanofi
Jason Ekert
Head of US Translational Technology,
UCB
Jennifer Busby
Director Biology,
Exscientia
Julie Owen
Director,
Recursion Pharmaceuticals
Lihua Yu
Chief Data Officer,
LifeMine Therapeutics
Martin Redhead
Associate Vice President,
Exscientia
Paul Scola
Senior Director, Chemistry,
Bristol Myers Squibb
Shelley Allen
Vice President, Head of Drug Discovery,
Nimble Therapeutics
Aaron Van Hooser
Senior Director, Computational Biology,
Sensorium Therapeutics
Anneke den Hollander
Head of Cellular Genomics, Genome Biology and Functional Genomics,
AbbVie
Ari Allyn-Feuer
Director of Artificial Intelligence Product,
GSK
Boguslaw Nocek
Senior Director,
Eli Lilly
Dr. Hemachandran Kannan
Director of the AI Research Centre,
Woxsen University
Graham Dempsey
Founder & Chief Scientific Officer,
Quiver Bioscience
Gvido Cebers
Global Head of Drug Safety, Research & Evaluation,
Takeda Pharmaceuticals
Ilkay Us
Director, High Throughput Screening,
Cornell University
Jody Logan
Senior Director of Tech Transfer,
Genentech
Jonathan Solomon
Director,
Novartis Pharma
Joseph Wu
Director, Stanford Cardiovascular Institute; Co-Founder, Greenstone Biosciences,
Stanford University
Judith Ronau
Senior Scientist,
AbbVie
Julia Fox
Director, Data & Analytics,
Takeda
Kian Tan
Director,
Novartis
Lena Dolgikh
Head of CADD,
Monte Rosa Therapeutics
Nicholas Larsen
Senior Director of Biophysics and Structural Biology,
Kestrel Therapeutics
Noel Powell
Senior Director -Medicinal Chemistry,
Recursion Pharmaceuticals
Prashant Gahtori
Professor,
Graphic Era Hill University
Rick Ewing
Vice President, Head of Chemistry,
Rapafusyn Pharmaceuticals
Robert Fremeau
Founder & CSO,
BrainStorm Therapeutics
Shuying He
Senior Director, External Innovation,
Eli Lilly
Yuan Wang
Head, Research Analytics,
UCB
Yunhui Ge
Scientist,
Alkermes
Meet Our Esteemed Sponsors
Gold Sponsors
Silver Sponsors
XtalPi
Silver Sponsor
XtalPi is a global technology platform company powered by artificial intelligence (AI) and robotics. Founded in 2015, XtalPi is dedicated to driving intelligent and digital transformation in life sciences and discovering better therapeutics and new materials. By integrating and synergizing quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of innovative solutions, services, and products to empower our partners in the biopharmaceutical, chemical, new energy, and new materials sectors worldwide.
Bronze Sponsors
Network & Programme Sponsors
.jpg)
Building Partnerships & Fostering An Inter-Disciplinary Approach In The Fight Against Anti-Microbial Resistance
This article outlines two examples of partnerships that aim to tackle the global issue of anti-microbial resistance. This overlooked yet prominent threat continues to pose challenges for scientists, policymakers, and governments.
Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Alzheimer's & Brain Awareness Month Spotlight: How Amphista Therapeutics is Tackling Neurological Disorders
To honour Alzheimer's & Brain Awareness Month, this article will acknowledge Amphista Therapeutics' use of targeted protein degradation (TPD) to treat symptoms of neurological disorders.
Euroscreen Fast Assay Development and High-Throughput Screening Services
Pelago Bioscience - CETSA® Technology
Boston Marriott Cambridge
50 Broadway, Cambridge, MA 02142, United States
Public Transportation:
The nearest Bus station is South Station.
The nearest Subway station is Kendall/MIT.
The nearest Train stations are North Station and South Station.
For more information, please click here.
By Air:
Boston Logan International Airport is the nearest airport to the venue – 5 miles from the property.
For more information, please call +1 800-2356426 or click here.
Parking:
On site valet parking: $58.99 (valet with in/out privileges)
Off site self-parking: $48.00 daily (no in/out privileges)
Information regarding accommodation for this event will be added soon
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Discovery US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
